Author

Joshua D. Bromley

Broad InstituteORCID 0000-0001-8692-2740Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 3 Organism:human· 3 Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Assay:scRNA-seq· 2 Assay:bulk RNA-seq· 1 Research Focus:cell-cell communication· 1 Research Focus:clustering· 1

Frequent Co-Authors

Alex K. ShalekiD· 3 shared Samira Ibrahim· 2 shared Sarah K. NyquistiD· 2 shared Tasneem Jivanjee· 2 shared Aaron D. Richardson· 1 shared Adam ParkeriD· 1 shared Alejandro HochkoeppleriD· 1 shared Alessandra StefaniD· 1 shared

Activity by Year

2022-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 35 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

Alex K. ShalekORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

ImmunologyNature ImmunologyPeer-reviewedJan 20, 2025

Impact of variants and vaccination on nasal immunity across three waves of SARS-CoV-2

Jaclyn M. L. Walsh, Vincent N. Miao, Anna H. Owings…·José Ordovás-Montañés

This study examines how SARS-CoV-2 variants and vaccination affect nasal immunity across three waves, identifying changes in cellular states and immune responses.

16 citationstop 1%

humanscRNA-seq

𝕏 PostBluesky

ImmunologybioRxivPreprintMay 24, 2024

Systematic deconstruction of myeloid cell signaling in tuberculosis granulomas reveals IFN-γ, TGF-β, and time are associated with conserved myeloid diversity

Joshua M. Peters, Hannah Priyadarshini Gideon, Travis K. Hughes…·Bryan D. Bryson

This study uses multi-omics approaches to analyze myeloid cell diversity in TB granulomas and identifies IFN-γ, TGF-β, and time as factors driving macrophage diversity.

4 citations

non-human primatehuman

𝕏 PostBluesky

Molecular BiologybioRxivPreprintDec 7, 2022

Expanding the HDAC druggable landscape beyond enzymatic activity

Julien Olivet, Soon Gang Choi, Salvador Sierra…·Marc Vidal

This paper identifies a non-enzymatic HDAC inhibitor with anti-tumor and anti-psychedelic effects, showing reduced gene modulation compared to enzymatic inhibitors.

1 citation

humanexperimental assay

𝕏 PostBluesky